CareDx Statistics
Total Valuation
CareDx has a market cap or net worth of $1.15 billion. The enterprise value is $939.02 million.
Important Dates
The next estimated earnings date is Wednesday, February 26, 2025, after market close.
| Earnings Date | Feb 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CareDx has 53.63 million shares outstanding. The number of shares has decreased by -2.33% in one year.
| Current Share Class | 53.63M |
| Shares Outstanding | 53.63M |
| Shares Change (YoY) | -2.33% |
| Shares Change (QoQ) | +1.36% |
| Owned by Insiders (%) | 2.48% |
| Owned by Institutions (%) | 95.27% |
| Float | 52.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 44.30 |
| PS Ratio | 3.60 |
| Forward PS | 3.20 |
| PB Ratio | 4.17 |
| P/TBV Ratio | 5.97 |
| P/FCF Ratio | 941.01 |
| P/OCF Ratio | 147.84 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 768.43 |
Financial Position
The company has a current ratio of 4.10, with a Debt / Equity ratio of 0.11.
| Current Ratio | 4.10 |
| Quick Ratio | 3.78 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | 24.52 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -43.02% and return on invested capital (ROIC) is -10.02%.
| Return on Equity (ROE) | -43.02% |
| Return on Assets (ROA) | -7.50% |
| Return on Capital (ROIC) | -10.02% |
| Revenue Per Employee | $486,431 |
| Profits Per Employee | -$223,263 |
| Employee Count | 643 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 5.75 |
Taxes
In the past 12 months, CareDx has paid $304,000 in taxes.
| Income Tax | 304,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +102.46% in the last 52 weeks. The beta is 1.86, so CareDx's price volatility has been higher than the market average.
| Beta (5Y) | 1.86 |
| 52-Week Price Change | +102.46% |
| 50-Day Moving Average | 22.94 |
| 200-Day Moving Average | 20.71 |
| Relative Strength Index (RSI) | 43.79 |
| Average Volume (20 Days) | 851,038 |
Short Selling Information
The latest short interest is 3.97 million, so 7.40% of the outstanding shares have been sold short.
| Short Interest | 3.97M |
| Short Previous Month | 3.12M |
| Short % of Shares Out | 7.40% |
| Short % of Float | 7.59% |
| Short Ratio (days to cover) | 5.60 |
Income Statement
In the last 12 months, CareDx had revenue of $312.78 million and -$143.56 million in losses. Loss per share was -$2.74.
| Revenue | 312.78M |
| Gross Profit | 205.71M |
| Operating Income | -58.72M |
| Pretax Income | -159.61M |
| Net Income | -143.56M |
| EBITDA | -44.26M |
| EBIT | -58.72M |
| Loss Per Share | -$2.74 |
Full Income StatementBalance Sheet
The company has $240.85 million in cash and $29.97 million in debt, giving a net cash position of $210.89 million or $3.93 per share.
| Cash & Cash Equivalents | 240.85M |
| Total Debt | 29.97M |
| Net Cash | 210.89M |
| Net Cash Per Share | $3.93 |
| Equity (Book Value) | 273.25M |
| Book Value Per Share | 5.15 |
| Working Capital | 252.65M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $7.78 million and capital expenditures -$6.56 million, giving a free cash flow of $1.22 million.
| Operating Cash Flow | 7.78M |
| Capital Expenditures | -6.56M |
| Free Cash Flow | 1.22M |
| FCF Per Share | $0.02 |
Full Cash Flow StatementMargins
Gross margin is 65.77%, with operating and profit margins of -18.77% and -45.90%.
| Gross Margin | 65.77% |
| Operating Margin | -18.77% |
| Pretax Margin | -45.80% |
| Profit Margin | -45.90% |
| EBITDA Margin | -14.15% |
| EBIT Margin | -18.77% |
| FCF Margin | 0.39% |
Dividends & Yields
CareDx does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.33% |
| Shareholder Yield | 2.33% |
| Earnings Yield | -12.48% |
| FCF Yield | 0.11% |
Analyst Forecast
The average price target for CareDx is $26.43, which is 23.27% higher than the current price. The consensus rating is "Buy".
| Price Target | $26.43 |
| Price Target Difference | 23.27% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 16.15% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CareDx has an Altman Z-Score of 0.97 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.97 |
| Piotroski F-Score | 4 |